Stay updated on Vertex Pharmaceuticals Press Releases
Sign up to get notified when there's something new on the Vertex Pharmaceuticals Press Releases page.
Latest updates to the Vertex Pharmaceuticals Press Releases page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page has removed a significant announcement regarding Vertex's approval for KALYDECO, while adding information about upcoming investor conferences.SummaryDifference4%
- Check17 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference3%
- Check24 days agoChange DetectedThe webpage has been updated to include new financial results and clinical study announcements from Vertex, while previous announcements regarding advancements in pain treatment and a licensing agreement have been removed.SummaryDifference7%
- Check46 days agoChange DetectedVertex has been recognized as a winner at the Premier, Inc. Breakthroughs Innovation Celebration for its non-opioid treatment JOURNAVX™, and has secured a broad reimbursement agreement with NHS England for ALYFTREK®, a new treatment for cystic fibrosis.SummaryDifference8%
- Check53 days agoChange DetectedThe page has updated its financial results announcement date and removed a previous clinical trial update.SummaryDifference4%
- Check60 days agoChange DetectedThe page now includes an announcement regarding the European Commission's approval of ALYFTREK, a new treatment for cystic fibrosis, while the previous announcement about FDA clearance for VX-407 has been removed.SummaryDifference5%
Stay in the know with updates to Vertex Pharmaceuticals Press Releases
Enter your email address, and we'll notify you when there's something new on the Vertex Pharmaceuticals Press Releases page.